First Time Loading...
S

Shandong Sanyuan Biotechnology Co Ltd
SZSE:301206

Watchlist Manager
Shandong Sanyuan Biotechnology Co Ltd
SZSE:301206
Watchlist
Price: 26.03 CNY 1.48% Market Closed
Updated: Apr 25, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Shandong Sanyuan Biotechnology Co Ltd

Wall Street analysts forecast Shandong Sanyuan Biotechnology Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shandong Sanyuan Biotechnology Co Ltd is 32.64 CNY with a low forecast of 32.32 CNY and a high forecast of 33.6 CNY.

Lowest Forecast
Wall Street Target
32.32 CNY
24% Upside
Average Forecast
Wall Street Target
32.64 CNY
25% Upside
Highest Forecast
Wall Street Target
33.6 CNY
29% Upside
Lowest
Price Target
32.32 CNY
24% Upside
Average
Price Target
32.64 CNY
25% Upside
Highest
Price Target
33.6 CNY
29% Upside
Shandong Sanyuan Biotechnology Co Ltd Competitors:
Price Targets
ZSK
Sunopta Inc
208% Upside
MKC
McCormick & Company Inc
4% Upside
BMK
Benchmark Holdings PLC
23% Upside
2220
Kameda Seika Co Ltd
3% Downside
ZSK
Sunopta Inc
208% Upside
MKC
McCormick & Company Inc
4% Upside
BMK
Benchmark Holdings PLC
23% Upside
2220
Kameda Seika Co Ltd
3% Downside
W
WWL
Wawel SA
2% Upside
F
2283
First Milling Company SJSC
9% Upside
2270
Saudia Dairy and Foodstuff Company SJSC
13% Upside
TWNK
Hostess Brands Inc
2% Upside

Revenue
Forecast

Revenue Estimate
Shandong Sanyuan Biotechnology Co Ltd

For the last 8 years the compound annual growth rate for Shandong Sanyuan Biotechnology Co Ltd's revenue is 55%. The projected CAGR for the next 2 years is -1%.

55%
Past Growth
-1%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Shandong Sanyuan Biotechnology Co Ltd

For the last 8 years the compound annual growth rate for Shandong Sanyuan Biotechnology Co Ltd's operating income is 63%. The projected CAGR for the next 2 years is 79%.

63%
Past Growth
79%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Shandong Sanyuan Biotechnology Co Ltd

For the last 8 years the compound annual growth rate for Shandong Sanyuan Biotechnology Co Ltd's net income is 105%. The projected CAGR for the next 2 years is -13%.

105%
Past Growth
-13%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shandong Sanyuan Biotechnology Co Ltd's stock price target?
Price Target
32.64 CNY

According to Wall Street analysts, the average 1-year price target for Shandong Sanyuan Biotechnology Co Ltd is 32.64 CNY with a low forecast of 32.32 CNY and a high forecast of 33.6 CNY.

What is Shandong Sanyuan Biotechnology Co Ltd's Revenue forecast?
Projected CAGR
-1%

For the last 8 years the compound annual growth rate for Shandong Sanyuan Biotechnology Co Ltd's revenue is 55%. The projected CAGR for the next 2 years is -1%.

What is Shandong Sanyuan Biotechnology Co Ltd's Operating Income forecast?
Projected CAGR
79%

For the last 8 years the compound annual growth rate for Shandong Sanyuan Biotechnology Co Ltd's operating income is 63%. The projected CAGR for the next 2 years is 79%.

What is Shandong Sanyuan Biotechnology Co Ltd's Net Income forecast?
Projected CAGR
-13%

For the last 8 years the compound annual growth rate for Shandong Sanyuan Biotechnology Co Ltd's net income is 105%. The projected CAGR for the next 2 years is -13%.

ALPHA SPREAD
Join more than 131,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.